A detailed history of Sanibel Captiva Trust Company, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sanibel Captiva Trust Company, Inc. holds 35,320 shares of BMY stock, worth $1.99 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
35,320
Previous 24,005 47.14%
Holding current value
$1.99 Million
Previous $997 Million 83.31%
% of portfolio
0.06%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$39.66 - $51.75 $448,752 - $585,551
11,315 Added 47.14%
35,320 $1.83 Billion
Q2 2024

Jul 22, 2024

BUY
$40.25 - $52.99 $183,097 - $241,051
4,549 Added 23.38%
24,005 $997 Million
Q1 2024

May 21, 2024

SELL
$47.98 - $54.4 $64,629 - $73,276
-1,347 Reduced 6.48%
19,456 $1.06 Billion
Q4 2023

Feb 16, 2024

BUY
$48.48 - $57.85 $1.01 Million - $1.2 Million
20,803 New
20,803 $1.07 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Sanibel Captiva Trust Company, Inc. Portfolio

Follow Sanibel Captiva Trust Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sanibel Captiva Trust Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sanibel Captiva Trust Company, Inc. with notifications on news.